These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6166217)

  • 1. Role of histamine in the hypotensive action of d-tubocurarine in humans.
    Moss J; Rosow CE; Savarese JJ; Philbin DM; Kniffen KJ
    Anesthesiology; 1981 Jul; 55(1):19-25. PubMed ID: 6166217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of d-tubocurarine on spontaneous postganglionic sympathetic activity and histamine release.
    McCullough LS; Reier CE; Delaunois AL; Gardier RW; Hamelberg W
    Anesthesiology; 1970 Sep; 33(3):328-34. PubMed ID: 4195404
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of prostacyclin to D-tubocurarine-induced hypotension in humans.
    Hatano Y; Arai T; Noda J; Komatsu K; Shinkura R; Nakajima Y; Sawada M; Mori K
    Anesthesiology; 1990 Jan; 72(1):28-32. PubMed ID: 2105067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma N-methylhistamine concentration as an indicator of histamine release by intravenous d-tubocurarine in humans: preliminary study in five patients by radioimmunoassay kits.
    Takeda J; Ueda E; Takahashi J; Fukushima K
    Anesth Analg; 1995 May; 80(5):1015-7. PubMed ID: 7537026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine antagonists and d-tubocurarine-induced hypotension in cardiac surgical patients.
    Inada E; Philbin DM; Machaj V; Moss J; D'Ambra MN; Rosow CE; Akins CW
    Clin Pharmacol Ther; 1986 Nov; 40(5):575-80. PubMed ID: 2429800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of histamine liberation with atropine sulfate following administration of d-tubocurarine].
    Kubo K
    Anaesthesist; 1985 Oct; 34(10):502-7. PubMed ID: 2416236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tubocurarine on plasma histamine concentration in the rat. Correlation with the release of histamine from isolated mast cells.
    Kubota Y
    Br J Anaesth; 1986 Dec; 58(12):1397-403. PubMed ID: 2431703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dependence of a d-tubocurarine-induced hypotension on alveolar concentration of halothane, dose of d-tubocurarine, and nitrous oxide.
    Munger WL; Miller RD; Stevens WC
    Anesthesiology; 1974 May; 40(5):442-8. PubMed ID: 4132543
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effects of pipecuronium and tubocurarine on plasma concentrations of histamine in humans.
    Naguib M; Abdulatif M; Absood A
    Br J Anaesth; 1991 Sep; 67(3):320-2. PubMed ID: 1654967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of d-tubocurarine-induced histamine release by halothane.
    Kettlekamp NS; Austin DR; Downes H; Cheek DB; Hirshman CA
    Anesthesiology; 1987 May; 66(5):666-9. PubMed ID: 2437835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of pancuronium and d-tubocurarine on blood histamine and sympathetic activity.
    DeLeo BC; Langley AE; Delaunois AL; Gardier RW
    Proc Soc Exp Biol Med; 1974 Nov; 147(2):354-6. PubMed ID: 4140526
    [No Abstract]   [Full Text] [Related]  

  • 12. Histamine liberation in surgical patients following administration of neuromuscular blocking drugs.
    Ertama PM
    Ann Clin Res; 1982 Feb; 14(1):15-26. PubMed ID: 6182834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use. I. Effects of doses and infusion rate on blood pressure, heart rate and plasma histamine concentration.
    Furuhata K; Hayakawa H; Soumi K; Arai H; Watanabe Y; Narita H
    Biol Pharm Bull; 1998 May; 21(5):456-60. PubMed ID: 9635499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine release by four narcotics: a double-blind study in humans.
    Flacke JW; Flacke WE; Bloor BC; Van Etten AP; Kripke BJ
    Anesth Analg; 1987 Aug; 66(8):723-30. PubMed ID: 2440351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Lien CA; Belmont MR; Abalos A; Eppich L; Quessy S; Abou-Donia MM; Savarese JJ
    Anesthesiology; 1995 May; 82(5):1131-8. PubMed ID: 7537945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine-releasing properties of Polysorbate 80 in vitro and in vivo: correlation with its hypotensive action in the dog.
    Masini E; Planchenault J; Pezziardi F; Gautier P; Gagnol JP
    Agents Actions; 1985 Sep; 16(6):470-7. PubMed ID: 2416204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine.
    Basta SJ; Savarese JJ; Ali HH; Moss J; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():105S-106S. PubMed ID: 6190488
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe bronchospasm and circulatory collapse following the administration of d-tubocurarine.
    Takki S; Tammisto T
    Ann Clin Res; 1971 Apr; 3(2):112-5. PubMed ID: 4104054
    [No Abstract]   [Full Text] [Related]  

  • 19. A method for determining whether hypotension caused by novel compounds in preclinical development results from histamine release.
    Blom JD; Yang PC; Nicholson NS; Case BL; Parlow JJ; South MS; Wegner CD
    J Pharmacol Toxicol Methods; 2004; 49(1):31-7. PubMed ID: 14670692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the H1 and H2 receptor antagonists, terfenadine and ranitidine on the hypotensive and gastric pH effects of the histamine releasing drugs, morphine and tubocurarine.
    Treuren BC; Galletly DC; Robinson BJ; Short TG; Ure RW
    Anaesthesia; 1993 Sep; 48(9):758-62. PubMed ID: 8214491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.